Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 25.06.18 in Vol 7, No 6 (2018): June

This paper is in the following e-collection/theme issue:

Works citing "Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study"

Tomiki Sumiyoshi, Koichiro Watanabe, Shinichi Noto, Shigeru Sakamoto, Yoshiya Moriguchi, Shuichi Okamoto

JMIR Res Protoc 2018 (Jun 25); 7(6):e161 

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.9682):

(note that this is only a small subset of citations)

  1. Sumiyoshi T, Watanabe K, Noto S, Sakamoto S, Moriguchi Y, Tan KHX, Hammer-Helmich L, Fernandez J. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross–sectional analysis of baseline data from PERFORM-J. Journal of Affective Disorders 2019;258:172
    CrossRef
  2. Li X, Sun N, Yang C, Liu Z, Li X, Zhang K. C-Reactive Protein Gene Variants in Depressive Symptoms & Antidepressants Efficacy. Psychiatry Investigation 2019;16(12):940
    CrossRef
  3. Sumiyoshi T, Watanabe K, Noto S, Sakamoto S, Moriguchi Y, Hammer-Helmich L, Fernandez J. Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J. Neuropsychiatric Disease and Treatment 2021;Volume 17:945
    CrossRef
  4. Noto S, Wake M, Mishiro I, Hammer-Helmich L, Ren H, Moriguchi Y, Fujikawa K, Fernandez J. Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy. Value in Health Regional Issues 2022;30:127
    CrossRef
  5. Watanabe K, Marumoto T, Ge H, Moriguchi Y, Fujikawa K, Fernandez JL. Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder. Journal of Psychiatric Research 2022;154:324
    CrossRef
  6. Sumiyoshi T, Hoshino T, Mishiro I, Hammer-Helmich L, Ge H, Moriguchi Y, Fujikawa K, Fernandez JL. Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder. Journal of Affective Disorders 2022;296:95
    CrossRef
  7. Sumiyoshi T, Uchida H, Watanabe K, Oosawa M, Ren H, Moriguchi Y, Fujikawa K, Fernandez J. Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 2022;Volume 18:2507
    CrossRef
  8. Toyoshima K, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I. The mediating role of depressive symptoms and subjective cognitive dysfunction in the relationship between stressful life events and functional disability in adult community volunteers. Journal of Affective Disorders 2023;330:110
    CrossRef
  9. Kim HK, Voineskos AN, Neufeld NH, Alexopoulos GS, Bingham KS, Flint AJ, Marino P, Rothschild AJ, Whyte EM, Mulsant BH. Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features. Molecular Psychiatry 2024;
    CrossRef